Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 22, 2023 (Week 29)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 15,153 32,023 770,779 863,388
New England 191 1,468 23,034 27,828
Connecticut - 251 1,156 5,887
Maine 47 78 1,585 1,780
Massachusetts 12 709 15,463 15,100
New Hampshire 2 93 1,339 1,702
Rhode Island 94 694 2,720 2,664
Vermont 36 37 771 695
Middle Atlantic 2,808 4,218 107,293 106,412
New Jersey 455 788 19,015 18,330
New York (excluding New York City) 905 1,032 22,589 21,734
New York City 495 1,457 35,858 35,741
Pennsylvania 953 1,233 29,831 30,607
East North Central 1,733 4,840 104,746 126,611
Illinois 81 1,518 27,725 39,237
Indiana 305 858 15,924 18,441
Michigan 204 975 17,649 23,561
Ohio 730 1,223 29,639 30,865
Wisconsin 413 561 13,809 14,507
West North Central 845 2,119 48,141 56,094
Iowa 180 334 7,501 8,215
Kansas 95 300 2,383 7,793
Minnesota 94 496 11,831 12,334
Missouri 351 729 17,175 17,676
Nebraska 124 220 4,896 5,346
North Dakota - 92 1,758 1,996
South Dakota 1 125 2,597 2,734
South Atlantic 3,122 7,251 167,665 190,274
Delaware - 420 3,090 5,612
District of Columbia - 191 3,996 4,524
Florida 1,863 2,787 60,376 58,586
Georgia - 1,599 25,991 40,667
Maryland U NC U U
North Carolina 14 1,432 30,432 36,443
South Carolina 524 884 18,298 20,112
Virginia 695 976 23,150 21,957
West Virginia 26 107 2,332 2,373
East South Central 1,175 2,503 56,049 59,021
Alabama 709 972 19,015 17,073
Kentucky 305 425 8,704 10,029
Mississippi 161 527 9,668 10,537
Tennessee - 1,094 18,662 21,382
West South Central 580 4,937 80,361 130,708
Arkansas 219 400 8,713 10,019
Louisiana 317 801 19,034 20,414
Oklahoma 44 422 5,874 10,975
Texas - 3,406 46,740 89,300
Mountain 1,389 2,507 56,868 65,425
Arizona 447 918 21,862 22,839
Colorado 423 651 14,100 14,189
Idaho 87 155 3,147 3,123
Montana 40 112 1,588 2,297
Nevada 151 360 4,229 9,532
New Mexico 15 257 4,930 6,256
Utah 199 249 6,127 6,238
Wyoming 27 54 885 951
Pacific 3,310 5,046 126,622 101,015
Alaska 51 121 2,125 2,973
California 2,394 4,111 105,148 72,679
Hawaii - 2 - 68
Oregon 335 362 8,373 8,775
Washington 530 635 10,976 16,520
U.S. Territories 2 124 1,138 2,669
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico 2 124 1,138 2,669
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 7 30 75
Total 15,156 32,123 771,947 866,132
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.